Showcasing Salspera’s Clinical Program Success to Demonstrate Scientific Credibility & Unlock Strategic Partnership Opportunities
- Presenting clinical results from Salspera’s microbiome therapeutic program to counter pharma skepticism and demonstrate evidence-based proof of concept in targeted disease indications
- Examining strategic business development decisions including therapeutic area prioritization and partnership models to share learnings on building commercially viable microbiome programs
- Leveraging clinical success to identify and connect with potential strategic partners, investors, and industry players to accelerate Salspera’s next phase of development